It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...
With its vaccine schedule, “Denmark has made a values choice to accept preventable hospitalizations and illnesses that other ...
BioMarin's new CEO had promised Wall Street there would be deals, and with Amicus, it has one the market likes.
Nine drugmakers are set to unveil deals with the Trump administration to lower the prices of some of their drugs, marking the ...
A vaccine adviser at the CDC with ties to health secretary Robert F. Kennedy Jr. is being given a new portfolio overseeing ...
WASHINGTON — Brand drugmakers have agreed to donate bulk ingredients to a national stockpile as part of deals with the Trump ...
UnitedHealth Group said Friday that the consultants it hired to audit its operations found they’re not only “robust,” but ...
BioMarin said it is acquiring Amicus Therapeutics, maker of rare-disease drugs, for $4.8 billion. A new FDA program meant to ...
An FDA program to fast-track drug reviews has become a way for the White House to influence which medicines make their way fastest to patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback